Repetitive Lab Test Restrictions

June 20, 2018- Restrictions on the frequency of ordering will be placed on 67 lab tests based on best practices and with with the input and review of McLaren physician leaders at multiple levels: Repetitive Testing Task Force, HVC Steering Committee, and Subsidiary HVC Teams.

Clinical Practice Update Video

Printable Infographic

McLaren HVC Infographic_180620 (3).pdf

Questions or concerns about this Clinical Practice Update? Click here to contact the McLaren HVC Program.

Repetitive Testing Restriction Rules

McLaren Repetitive Testing Limits_update.pdf

Repeat Normal Testing Restriction Rules

McLaren Repeat Normal Limits_update.pdf

Other Resources

Peer reviewed articles

Eaton KP, et al (2017). Evidence-Based Guidelines to Eliminate Repetitive Laboratory Testing. JAMA Internal Medicine, 177(12), 1833–1839.

Konger RL, et al (2016). Reduction in Unnecessary Clinical Laboratory Testing Through Utilization Management at a US Government Veterans Affairs Hospital. American Journal of Clinical Pathology, 145(3), 355–64.

Procop GW, et al (2015). Reducing duplicate testing: a comparison of two clinical decision support tools. American Journal of Clinical Pathology, 143(5), 623–6.

Yeh, DD (2014). A clinician’s perspective on laboratory utilization management. Clinica Chimica Acta; International Journal of Clinical Chemistry, 427, 145–50.

Click here to request full text articles.